bioAffinity Announces Publication Of Clinical Review And White Paper For Incorporating CyPath Lung Into Pulmonary Nodule Evaluation And Cancer Surveillance

Titled "Lung Nodules, Lung Microenvironment, Predictive Models and Clinician Risk Stratification Using CyPath® Lung Testing for Early Diagnosis of Lung Cancer," the paper examines the growing clinical challenge of evaluating pulmonary nodules as lung cancer screening expands, incidental findings increase, artificial intelligence identifies even more incidental nodules, and more patients require long-term surveillance following cancer treatment.

The complete white paper is available at https://bit.ly/cypath-lung-whitepaper3.